Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Neuromodulation Devices and Implantable Infusion Pumps market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Neuromodulation Devices and Implantable Infusion Pumps market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Neuromodulation devices and implantable infusion pumps are medical devices used in the field of neurology to treat various neurological conditions. Neuromodulation devices, such as deep brain stimulation (DBS) systems, spinal cord stimulators (SCS), and transcranial magnetic stimulation (TMS) devices, deliver targeted electrical or magnetic stimuli to specific areas of the nervous system to modulate abnormal neural activity and alleviate symptoms. DBS systems involve surgically implanting electrodes in the brain and connecting them to a pulse generator, which delivers electrical impulses to targeted brain regions. SCS devices use electrical stimulation in the spinal cord to manage chronic pain. TMS devices employ magnetic fields to non-invasively stimulate particular brain regions to treat conditions like depression and migraines.
Implantable infusion pumps, on the other hand, are used to deliver medications directly into the body, typically via a catheter or tube connected to the pump. These pumps are implanted surgically under the skin and are programmable to deliver precise doses of medications, such as pain relievers, muscle relaxants, or anti-spasticity drugs, directly to the spinal cord or specific areas of the brain.
Both neuromodulation devices and implantable infusion pumps provide targeted therapy for neurological conditions, offering a more precise and effective approach compared to systemic drug delivery methods. They are utilized in the management of conditions such as chronic pain, movement disorders (like Parkinson’s disease), epilepsy, obsessive-compulsive disorder (OCD), and other neurological disorders. These devices require careful evaluation, patient selection, and ongoing monitoring to ensure safety and optimize therapeutic outcomes.
The major global manufacturers of Neuromodulation Devices and Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Neuromodulation Devices and Implantable Infusion Pumps. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neuromodulation Devices and Implantable Infusion Pumps market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Neuromodulation Devices and Implantable Infusion Pumps market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neuromodulation Devices and Implantable Infusion Pumps industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Include:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Neuromodulation Devices and Implantable Infusion Pumps Product Segment Include:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Neuromodulation Devices and Implantable Infusion Pumps Product Application Include:
Parkinson＇s disease
Epilepsy
Pain
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Neuromodulation Devices and Implantable Infusion Pumps Industry PESTEL Analysis
Chapter 3: Global Neuromodulation Devices and Implantable Infusion Pumps Industry Porter's Five Forces Analysis
Chapter 4: Global Neuromodulation Devices and Implantable Infusion Pumps Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Neuromodulation Devices and Implantable Infusion Pumps Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Neuromodulation Devices and Implantable Infusion Pumps market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Neuromodulation Devices and Implantable Infusion Pumps market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Neuromodulation devices and implantable infusion pumps are medical devices used in the field of neurology to treat various neurological conditions. Neuromodulation devices, such as deep brain stimulation (DBS) systems, spinal cord stimulators (SCS), and transcranial magnetic stimulation (TMS) devices, deliver targeted electrical or magnetic stimuli to specific areas of the nervous system to modulate abnormal neural activity and alleviate symptoms. DBS systems involve surgically implanting electrodes in the brain and connecting them to a pulse generator, which delivers electrical impulses to targeted brain regions. SCS devices use electrical stimulation in the spinal cord to manage chronic pain. TMS devices employ magnetic fields to non-invasively stimulate particular brain regions to treat conditions like depression and migraines.
Implantable infusion pumps, on the other hand, are used to deliver medications directly into the body, typically via a catheter or tube connected to the pump. These pumps are implanted surgically under the skin and are programmable to deliver precise doses of medications, such as pain relievers, muscle relaxants, or anti-spasticity drugs, directly to the spinal cord or specific areas of the brain.
Both neuromodulation devices and implantable infusion pumps provide targeted therapy for neurological conditions, offering a more precise and effective approach compared to systemic drug delivery methods. They are utilized in the management of conditions such as chronic pain, movement disorders (like Parkinson’s disease), epilepsy, obsessive-compulsive disorder (OCD), and other neurological disorders. These devices require careful evaluation, patient selection, and ongoing monitoring to ensure safety and optimize therapeutic outcomes.
The major global manufacturers of Neuromodulation Devices and Implantable Infusion Pumps include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Neuromodulation Devices and Implantable Infusion Pumps. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neuromodulation Devices and Implantable Infusion Pumps market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Neuromodulation Devices and Implantable Infusion Pumps market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neuromodulation Devices and Implantable Infusion Pumps industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Include:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Neuromodulation Devices and Implantable Infusion Pumps Product Segment Include:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Neuromodulation Devices and Implantable Infusion Pumps Product Application Include:
Parkinson＇s disease
Epilepsy
Pain
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Neuromodulation Devices and Implantable Infusion Pumps Industry PESTEL Analysis
Chapter 3: Global Neuromodulation Devices and Implantable Infusion Pumps Industry Porter's Five Forces Analysis
Chapter 4: Global Neuromodulation Devices and Implantable Infusion Pumps Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Neuromodulation Devices and Implantable Infusion Pumps Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Neuromodulation Devices and Implantable Infusion Pumps Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Neuromodulation Devices and Implantable Infusion Pumps Product by Type
- 1.2.1 Spinal Cord Stimulation
- 1.2.2 Deep Brain Stimulation
- 1.2.3 Sacral Nerve Stimulation
- 1.2.4 Vagal Nerve Stimulation
- 1.2.5 Gastric Stimulation
- 1.2.6 Transcranial magnetic Stimulation
- 1.2.7 Transcutaneous Electrical Stimulation
- 1.2.8 Other
- 1.3 Neuromodulation Devices and Implantable Infusion Pumps Product by Application
- 1.3.1 Parkinson＇s disease
- 1.3.2 Epilepsy
- 1.3.3 Pain
- 1.3.4 Other
- 1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Revenue and Sales Analysis
- 1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales Price Trend Analysis (2020-2032)
- 1.5 Neuromodulation Devices and Implantable Infusion Pumps Market Development Status and Trends
- 1.5.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Development Status Analysis
- 1.5.2 Neuromodulation Devices and Implantable Infusion Pumps Industry Development Trends Analysis
- 2 Neuromodulation Devices and Implantable Infusion Pumps Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Neuromodulation Devices and Implantable Infusion Pumps Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Country
- 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Sales Price by Manufacturers (2021-2025)
- 5.2 Neuromodulation Devices and Implantable Infusion Pumps Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Neuromodulation Devices and Implantable Infusion Pumps Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Type
- 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Revenue Analysis by Type
- 6.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Medtronic
- 7.1.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 7.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Boston Scientific Corporation
- 7.2.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 7.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Abbott
- 7.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 7.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Synapse Biomedical
- 7.4.1 Synapse Biomedical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
- 7.4.3 Synapse Biomedical Neuromodulation Devices and Implantab
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
